Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN109678853A reveals ionic liquid catalysis for Dasatinib. Enhances purity and supply chain reliability for pharmaceutical intermediate manufacturing partners globally.
Novel patent CN111454164B details efficient terbutaline sulfate synthesis reducing toxic waste and enhancing supply chain reliability for global pharmaceutical intermediates supplier networks.
Patent CN101824012B reveals a novel route for 2-(1,6,7,8-tetrahydro-2H-indeno-[5,4-b]furan-8-yl)acetonitrile, offering cost reduction in API manufacturing and high purity.
Patent CN117567288A details a novel asymmetric hydrogenation process for chiral alcohols, offering significant cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability.
Novel phase transfer catalysis method for 9-(2-hydroxyethyl)carbazole. Reduces side reactions, improves purity, ensures supply chain stability for pharmaceutical manufacturing.
Patent CN106334578B reveals efficient ionic liquid catalyst. Reduces cost and improves supply chain for pharmaceutical intermediates manufacturing globally.
Advanced synthesis of heteroaromatic quinazoline derivatives via patent CN101663303A. Delivers high-purity pharmaceutical intermediates with optimized supply chain reliability.
Patent CN101891678A details efficient Heck coupling for 4-(N,N-dimethyl)aminopyridine derivatives, offering cost reduction in chiral catalyst manufacturing and scalable pharma intermediate production.
Patent CN114456101A reveals a streamlined 3-step synthesis for PF-07321332 key intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN106334578B reveals ionic liquid catalyst for quinoline derivatives ensuring high purity and scalable manufacturing for reliable pharmaceutical intermediates supplier partnerships.
Patent CN113061094A details a cost-effective H-D exchange route for Ractopamine-D6. Achieve >98% purity and >96% isotopic abundance for LC-MS food safety testing.
Novel synthesis route for monocyclic beta-lactam compounds improves yield and purity while reducing environmental impact for pharmaceutical manufacturing.
Patent CN114380750B reveals high-yield deuteration route. Enhances supply chain reliability and reduces manufacturing costs for veterinary and pharmaceutical intermediates.
Patent CN121342678A enables one-pot synthesis for high purity Safinamide Mesylate. Reduces waste and cost for reliable pharmaceutical intermediate supply chains.
Novel 6-step route for 2'-deoxy-2'-beta-fluoro-4'-azidocytidine reduces cost and improves yield for reliable API manufacturing.
Patent CN109096126B details a mild, high-yield synthesis for D9-Clenbuterol. Discover cost-effective production strategies for high-purity isotopic standards.
Novel Cobalt-catalyzed synthesis offers high yield and selectivity for alpha fused ring carbon glycoside intermediates. Enables cost reduction and supply chain reliability for pharmaceutical manufacturing partners globally.
Novel SmI2-catalyzed reductive deuteration of nitriles offers high yield and regioselectivity. A cost-effective supply chain solution for deuterated drug manufacturing.
Advanced nitration process offers high purity and yield for antiviral intermediates. Scalable synthesis reduces costs and ensures supply continuity for global pharmaceutical manufacturers.
Patent CN102153585A details a safer, high-yield synthesis of Minodronic Acid intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.